ABBOTINDIA Overzicht aandelen
Abbott India Limited is samen met haar dochterondernemingen actief als farmaceutisch bedrijf in India. Meer informatie
| Sneeuwvlok Score | |
|---|---|
| Waardering | 0/6 |
| Toekomstige groei | 3/6 |
| Prestaties in het verleden | 5/6 |
| Financiële gezondheid | 6/6 |
| Dividenden | 5/6 |
Abbott India Limited Concurrenten
Prijsgeschiedenis en prestaties
| Historische aandelenkoersen | |
|---|---|
| Huidige aandelenkoers | ₹27,378.30 |
| 52 Week Hoogtepunt | ₹30,521.00 |
| 52 Week Laag | ₹22,000.00 |
| Bèta | 0.013 |
| 11 maand verandering | -3.84% |
| 3 maanden verandering | -9.33% |
| 1 Jaar Verandering | 15.01% |
| 33 jaar verandering | 44.06% |
| 5 jaar verandering | 114.35% |
| Verandering sinds IPO | 3,469.53% |
Recent nieuws en updates
There's Reason For Concern Over Abbott India Limited's (NSE:ABBOTINDIA) Price
Oct 17
Is Abbott India (NSE:ABBOTINDIA) Using Too Much Debt?
Aug 31Recent updates
There's Reason For Concern Over Abbott India Limited's (NSE:ABBOTINDIA) Price
Oct 17Is Abbott India (NSE:ABBOTINDIA) Using Too Much Debt?
Aug 31Abbott India (NSE:ABBOTINDIA) Has Announced That It Will Be Increasing Its Dividend To ₹410.00
Jul 13Abbott India's (NSE:ABBOTINDIA) Upcoming Dividend Will Be Larger Than Last Year's
Jun 27Abbott India's (NSE:ABBOTINDIA) Shareholders Will Receive A Bigger Dividend Than Last Year
Jun 13Abbott India (NSE:ABBOTINDIA) Is Paying Out A Larger Dividend Than Last Year
May 12Is Abbott India (NSE:ABBOTINDIA) Using Too Much Debt?
Feb 23Abbott India Limited's (NSE:ABBOTINDIA) Business Is Yet to Catch Up With Its Share Price
Jan 07Abbott India's (NSE:ABBOTINDIA) Upcoming Dividend Will Be Larger Than Last Year's
Jul 15Abbott India (NSE:ABBOTINDIA) Will Pay A Larger Dividend Than Last Year At ₹325.00
Jul 01Abbott India (NSE:ABBOTINDIA) Has Announced That It Will Be Increasing Its Dividend To ₹325.00
May 22With EPS Growth And More, Abbott India (NSE:ABBOTINDIA) Makes An Interesting Case
Apr 14Is Abbott India (NSE:ABBOTINDIA) Using Too Much Debt?
Mar 06Is Now The Time To Put Abbott India (NSE:ABBOTINDIA) On Your Watchlist?
Dec 31We Think Abbott India (NSE:ABBOTINDIA) Can Manage Its Debt With Ease
Mar 16Here's Why We Think Abbott India (NSE:ABBOTINDIA) Is Well Worth Watching
Jan 28A Look At The Intrinsic Value Of Abbott India Limited (NSE:ABBOTINDIA)
Dec 05Do Abbott India's (NSE:ABBOTINDIA) Earnings Warrant Your Attention?
Oct 30Abbott India (NSE:ABBOTINDIA) Has A Rock Solid Balance Sheet
Sep 18Should You Be Adding Abbott India (NSE:ABBOTINDIA) To Your Watchlist Today?
Jul 16How Does Abbott India Limited (NSE:ABBOTINDIA) Stand Up To These Simple Dividend Safety Checks?
Mar 24The Abbott India (NSE:ABBOTINDIA) Share Price Is Up 197% And Shareholders Are Boasting About It
Mar 03Is Weakness In Abbott India Limited (NSE:ABBOTINDIA) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects?
Feb 04How Much Of Abbott India Limited (NSE:ABBOTINDIA) Do Institutions Own?
Jan 14
Abbott India Limited (NSE:ABBOTINDIA) Is An Attractive Dividend Stock - Here's Why
Dec 24Announcing: Abbott India (NSE:ABBOTINDIA) Stock Increased An Energizing 185% In The Last Five Years
Dec 03Is There More To The Story Than Abbott India's (NSE:ABBOTINDIA) Earnings Growth?
Nov 12Rendement voor aandeelhouders
| ABBOTINDIA | IN Pharmaceuticals | IN Markt | |
|---|---|---|---|
| 7D | 1.0% | 0.8% | 2.9% |
| 1Y | 15.0% | 42.1% | 28.9% |
Rendement versus industrie: ABBOTINDIA presteerde slechter dan de Indian Pharmaceuticals -sector, die het afgelopen jaar een rendement van 42.1 % opleverde.
Rendement versus markt: ABBOTINDIA presteerde slechter dan Indian Market, dat het afgelopen jaar een rendement van 28.9 % opleverde.
Prijsvolatiliteit
| ABBOTINDIA volatility | |
|---|---|
| ABBOTINDIA Average Weekly Movement | 2.8% |
| Pharmaceuticals Industry Average Movement | 6.0% |
| Market Average Movement | 6.1% |
| 10% most volatile stocks in IN Market | 9.0% |
| 10% least volatile stocks in IN Market | 4.0% |
Stabiele aandelenkoers: ABBOTINDIA heeft de afgelopen 3 maanden geen significante prijsvolatiliteit gekend.
Volatiliteit in de loop van de tijd: De wekelijkse volatiliteit ( 3% ) van ABBOTINDIA is het afgelopen jaar stabiel geweest.
Over het bedrijf
| Opgericht | Werknemers | CEO | Website |
|---|---|---|---|
| 1910 | 3,814 | Swati Dalal | www.abbott.co.in |
Abbott India Limited is, samen met haar dochterondernemingen, actief als farmaceutisch bedrijf in India. Het bedrijf biedt farmaceutische producten voor gastro-enterologie, vrouwengeneeskunde, metabolisme, centraal zenuwstelsel, vaccins en multispecialisme, waaronder slapeloosheid, vitamine D-tekort, vroeggeboorte en pijnbestrijding. Het biedt producten aan tegen infecties, cardio-diabetes, hepatologie, hormonen, neuro-psychiatrie, lever, gennext en consumentenzorg.
Abbott India Limited Samenvatting
| ABBOTINDIA fundamentele statistieken | |
|---|---|
| Marktkapitalisatie | ₹584.47b |
| Inkomsten(TTM) | ₹12.85b |
| Inkomsten(TTM) | ₹60.66b |
45.3x
Koers/Winstverhouding9.6x
P/S-verhoudingIs ABBOTINDIA overgewaardeerd?
Zie Reële waarde en waarderingsanalyseInkomsten en omzet
| ABBOTINDIA resultatenrekening (TTM) | |
|---|---|
| Inkomsten | ₹60.66b |
| Kosten van inkomsten | ₹33.43b |
| Brutowinst | ₹27.23b |
| Overige uitgaven | ₹14.39b |
| Inkomsten | ₹12.85b |
Laatst gerapporteerde inkomsten
Sep 30, 2024
Volgende inkomensdatum
n.v.t.
| Winst per aandeel (EPS) | 604.57 |
| Brutomarge | 44.89% |
| Nettowinstmarge | 21.18% |
| Schuld/Eigen Vermogen Verhouding | 0% |
Hoe presteerde ABBOTINDIA op de lange termijn?
Bekijk historische prestaties en vergelijking